Ibernón, MeritxellNavarro, MaruGoma, MontserratTango, ArielRap, OanaCabrera, CristinaSánchez, AnaRodriguez, NeusRuiz, Pilar2025-01-082025-01-082024-05-011460-2385https://hdl.handle.net/2445/217320Comunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024Diabetes Mellitus type 2 (DM2) leads to chronic kidney disease in a 30-40% of diabetic patients and it is the major cause of end stage renal disease (ESRD). The clinical course of diabetic kidney disease is very heterogeneous and there is a lack of agreement between clinical parameters and renal histology. Besides, lesions of non-diabetic kidney disease (NDRD) can coexist with lesions of diabetic nephropathy (DN) in two-thirds of kidney biopsies in patients with diabetes.4 p.application/pdfeng(c) Ibernón, Meritxell et al., 2024Nefropaties diabètiquesDiabetis no-insulinodependentMalalties del ronyóDiabetic nephropathiesNon-insulin-dependent diabetesKidney diseasesThe role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patientsinfo:eu-repo/semantics/conferenceObject2024-12-13info:eu-repo/semantics/openAccess